Lipoprotein(a) testing and levels among patients with atherosclerotic cardiovascular disease: a large single-centre experience from the United Arab Emirates - Top-Institutions - MDSpire

Lipoprotein(a) testing and levels among patients with atherosclerotic cardiovascular disease: a large single-centre experience from the United Arab Emirates

  • By

  • Yosef Manla

  • Laila AbdelWareth

  • Yazan Aljabery

  • Hani Sabbour

  • Ronney Shantouf

  • Fatemeh Mohammad

  • Bartlomiej Piechowski-Jozwiak

  • Terrence Lee St John

  • Wael Almahmeed

  • June 26, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Lipidology
    • Cardiovascular Research

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Preventive Cardiology
    • Lipidology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Lipidology
    • Epidemiology

  • #4

    Imperial College London
    Imperial College London

    London, N/A

    Key Differentiators

    • Cardiology
    • Lipidology
    • Translational Medicine

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Lipidology
    • Clinical Research

Original Source(s)

Lipoprotein(a) testing and levels among patients with atherosclerotic cardiovascular disease: a large single-centre experience from the United Arab Emirates

  • by Yosef Manla, Laila AbdelWareth, Yazan Aljabery, Hani Sabbour, Ronney Shantouf, Fatemeh Mohammad, Bartlomiej Piechowski-Jozwiak, Terrence Lee St John, Wael Almahmeed

  • June 26, 2025

Related Content

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis

Cardiovascular involvement in ankylosing spondylitis and axial spondyloarthritis: epidemiology, mechanisms, and clinical management